| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20010090 | HPV | ENSG00000180914.11 | protein_coding | OXTR | No | No | 5021 | B2R9L7 P30559 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | OXTR |
|---|---|
| DrugBank ID | DB01282 |
| Drug Name | Carbetocin |
| Target ID | BE0000844 |
| UniProt ID | P30559 |
| Regulation Type | agonist |
| PubMed IDs | 9760035; 15740719; 11752352 |
| Citations | Engstrom T, Barth T, Melin P, Vilhardt H: Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol. 1998 Aug 21;355(2-3):203-10.@@Gimpl G, Postina R, Fahrenholz F, Reinheimer T: Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin. Eur J Pharmacol. 2005 Mar 7;510(1-2):9-16.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. |
| Groups | Approved; Investigational |
| Direct Classification | Oligopeptides |
| SMILES | [H][C@]1(NC(=O)[C@H](CC2=CC=C(OC)C=C2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)[C@@H](C)CC |
| Pathways | |
| PharmGKB | PA164743086 |
| ChEMBL | CHEMBL3301668 |
